Menstrual Issues in Adolescents with Physical and Developmental Disabilities
Elisabeth H. Quint,
Elisabeth H. Quint
Department of Obstetrics and Gynecology, Division of Gynecology, University of Michigan Health System, Ann Arbor, Michigan, USA
Search for more papers by this authorElisabeth H. Quint,
Elisabeth H. Quint
Department of Obstetrics and Gynecology, Division of Gynecology, University of Michigan Health System, Ann Arbor, Michigan, USA
Search for more papers by this authorAddress for correspondence: Elisabeth H. Quint, M.D., University of Michigan Health System, Department of Obstetrics and Gynecology, L4000 Women's Hospital, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-0276. Voice: 734-764-8429; fax: 734-647-9727. [email protected]
Abstract
Puberty and menstruation are difficult issues for teens with disabilities and for their families as well. Irregular bleeding, mood swings, and problems with hygiene often complicate the delicate balance in the lives of these adolescents. The care provider is asked to help with the pubertal transition and the issues surrounding menstruation and reproductive health. This review will concentrate on the issues concerning menstruation that need special focus in teens with developmental disability (DD). The impact of the menstrual cycle on these teenagers, including hygiene issues, menstrual irregularities due to specific clinical circumstances, and treatment dilemmas associated with the use of hormonal medication will be discussed for this special group of teens.
References
- 1 Kaplowitz, P. 2006. Pubertal development in girls: secular trends. Curr. Opinion Obstet. Gynecol. 18: 487–491.
- 2 McDowell, M.A., D.J. Brody & J.P. Hughes. 2007. Has age at menarche changed? Results from the National Health and Nutrition Examination Survey (NHANES) 1999–2004. J. Adolesc. Health 40: 227–231.
- 3 Knickmeyer, R.C., S. Wheelwright, R. Hoekstra & S. Baron-Cohen. 2006. Age of menarche in females with autism spectrum conditions. Devel. Med. Child Neurol. 48: 1007–1008.
- 4 Worley, G., C.M. Houlihan, M.E. Herman-Giddens, et al . 2002. Secondary sexual characteristics in children with cerebral palsy and moderate to severe motor impairment: a cross-sectional survey. Pediatrics 110: 897–902.
- 5 Cento, R.M., M. Ciampelli, C. Proto, et al . 2001. Neuroendocrine features of pubertal development in females with mental retardation. Gynecol. Endocrinol. 15: 178–183.
- 6 Cento, R.M., L. Ragusa, C. Proto, et al . 1996. Basal body temperature curves and endocrine pattern of menstrual cycles in Down syndrome. Gynecol. Endocrinol. 10: 133–137.
- 7 Scola, P.S. & S.M. Pueschel. 1992. Menstrual cycles and basal body temperature curves in women with Down syndrome. Obstet. Gynecol. 79: 91–94.
- 8 Bauer, J., J.L. Isojarvi, A.G. Herzog, et al . 2002. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and treatment. J. Neurol. Neurosurg. Psych. 73: 121–125.
- 9 Bilo, L., R. Meo, C. Nappi, et al . 1988. Reproductive endocrine disorders in women with primary generalized epilepsy. Epilepsia 29: 612–619.
- 10 Herzog, A.G. & S.C. Schachter. 2001. Valproate and the polycystic ovarian syndrome: final thoughts. Epilepsia 42: 311–315.
- 11 Isojarvi, J.I.T., T.J. Latikainen, A.J. Pakarinen, et al . 1993. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N. Engl. J. Med. 329: 1383–1388.
- 12 Wieck, A. & P.M. Haddad. 2003. Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences: selective literature review. Br. J. Psych. 182: 199–204.
- 13 Cohen, W.I. 2006. Current dilemmas in Down syndrome clinical care: celiac disease, thyroid disorders, and atlanto-axial instability. Am. J. Med. Genet. Semin. Med. Genet. 142: 141–148.
- 14 Dizon, C.D., L.M. Allen & M.P. Ornstein. 2005. Menstrual and contraceptive issues among young women with developmental disability: a retrospective review of cases of the Hospital for Sick Children, Toronto. J. Ped. Adolescent. Gynecol. 18: 157–162.
- 15 Csermely, T., L. Halvax, M. Vizer et al . 2007. Relationship between adolescent amenorrhea and climacteric osteoporosis. Maturitas 56: 368–374.
- 16 Murphy, N.A. & E.R. Elias. 2006. Sexuality of children and adolescents with developmental disabilities. Pediatrics 118: 398–403.
- 17 Quint, E.H., T.E. Elkins, C.A. Sorg & S. Kope. 1999. The treatment of cyclical behavioral changes in women with mental disabilities. J. Ped. Adolesc. Gynecol. 12: 139–142.
- 18 American College of Obstetrics and Gynecology . 2000. ACOG practice Bulletin: Premenstrual Syndrome. Washington , DC .
- 19 Davis, A.R. & C.L. Westhoff. 2001. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J. Ped. Adolesc. Gynecol. 14: 3–8.
- 20 Borges, L.E., R.P. Andrade, J.M. Aldrighi, et al . 2006. Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception. Contraception 74: 446–450.
- 21 Wyatt, K.M., P.W. Dimmock & P.M O'Brien. 2005. Selective serotonin reuptake inhibitors for premenstrual syndrome. In The Cochrane Database of Systematic Reviews (3) Art. No: CD001396.
- 22 Gray, S.H. & S.J. Emans. 2007. Abnormal vaginal bleeding in adolescents. Ped. Rev. 28: 175–182.
- 23 Albanese, A. & N.W. Hopper. 2007. Suppression of menstruation in adolescents with severe learning disabilities. Arch. Dis. Child. 92: 629–32.
- 24 Bonnar, J. & B.L. Sheppard. 1996. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ 313: 579–582.
- 25 Edelman, A.B., M.F. Gallo, J.T. Jensen, et al . 2005. Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception. In Cochrane Database Syst. Rev. CD004695.
- 26 Sucato, G.S. & K.L. Gerschultz. 2005. Extended cycle hormonal contraception in adolescents. Curr. Opin. Obstet. Gynecol. 17: 461–465.
- 27 Rousseau, M.C. & B. Guillotel. 2001. Risk factors for deep venous thrombosis in tetraparesic mentally retarded patients. Brain Injury 15: 1041–1044.
- 28 Lohiya, G.S., F.M. Crinella, L. Tan-Figueroa & S. Go. 2005. Deep vein thrombosis in a tetraparesic patient with mental retardation: case report and review of the literature. Brain Injury 19: 739–742.
- 29 Schreijer, A.J., S.C. Cannegieter, J.C. Meijers, et al . 2006. Activation of coagulation system during air travel: a crossover study. Lancet 367: 832–838.
- 30 Tanis, B.C. & F.R. Rosendaal. 2003. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors. Semin. Vasc. Med. 3: 69–84.
- 31 Savelli, S.L., B.A. Kerlin, M.A. Springer, et al . 2006. Recommendations for screening for thrombophilic tendencies in teenage females prior to contraceptive initiation. J. Ped. Adolesc. Gynecol. 19: 313–316.
- 32 Cole, J.A., H. Norman, M. Doherty, et al . 2007. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstet. Gynecol. 109: 339–346.
- 33 DiVasta, A.D. & C.M. Gordon. 2006. Bone health in adolescents. Adolesc. Med. Clin. 17: 639–652.
- 34 Understanding the needs of women with epilepsy or risk OC failure. 1998. In Contraceptive Technol. Update 19: 109–1011.
- 35 Arias, R.D., J.K. Jain, C. Brucker, et al . 2006. Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg. Contraception 74: 234–238.
- 36 Westhoff, C., J.K. Jain, I. Milsom, et al . 2007. Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL. Contraception 75: 261–267.
- 37 Bonny, A., K. Camlin, R. Harvey, et al . 2003. Prospective analysis of weight changes in adolescent females initiating depot medroxyprogesterone acetate (DMPA), oral contraceptive pills, or no hormonal method. J. Adolesc. Health 32: 134.
- 38 Cromer, B.A., M. Stager, A. Bonny et al . 2004. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J. Adolesc. Health 35: 434–441.
- 39 Lopez, L.M., D.A. Grimes, K.F. Schulz, et al . 2006. Steroidal contraceptives: effect on bone fractures in women. In Cochrane Database of Systematic Reviews. (4):CD006033.
- 40 King, W., R. Levin, R. Schmidt, et al . 2003. Prevalence of reduced bone mass in children and adults with spastic quadriplegia. Dev. Med. Child. Neurol. 45: 12–16.
- 41 Henderson, R.C., R.K. Lark, M.J. Gurka, et al . 2002. Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics 110: 1–10.
- 42 Watson, K.C., M.J. Lentz & K.C. Cain. 2006. Associations between fracture incidence and use of depot medroxyprogesterone acetate and anti-epileptic drugs in women with developmental disabilities. Womens' Health Issues 16: 346–352.
- 43 Schrager, S., C. Kloss & A.W. Ju. 2007. Prevalence of fractures in women with intellectual disabilities: a chart review. J. Intellect. Disabil. Res. 51: 253–259.
- 44 Pluskiewicz, W., B. Drozdzowska, A. Lyssek-Boro, et al . 2006. Densitometric and quantitative ultrasound measurements and laboratory investigations in wheelchair-bound patients. J. Clin. Densitom. 9: 78–83.
- 45 Funk, S., M.M. Miller, D.R. Mishell, Jr., et al . 2005. The Implanon US Study Group. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception 71: 319–326.
- 46 Hidalgo, M., L. Bahamondes, M. Perrotti, et al . 2002. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception 65: 129–132.
- 47 Suhonen, S., M. Haukkamaa, T. Jakobsson & I. Rauramo. 2004. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception 69: 407–412.
- 48 Paransky, O.I. & R.K. Zurawin. 2003. Management of menstrual problems and contraception in adolescents with mental retardation: a medical, legal, and ethical review with new suggested guidelines. J. Pediat. Adolesc. Gynecol. 16: 223–235.
- 49 American College of Obstetrics and Gynecology . 1999. Sterilization of women, including those with mental disabilities. In ACOG Committee Opinion 216. Washington , DC .
Citing Literature
